Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.
about
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionGenetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkersNaming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophyDysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI.Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findingsA focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIsThe influence of Apolipoprotein E genotype on regional pathology in Alzheimer's diseaseFaster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.Atlas-based diffusion tensor imaging correlates of executive functionChildhood Learning Disabilities and Atypical Dementia: A Retrospective Chart ReviewPosterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adultsAdvanced psychometric analysis and the Alzheimer's Disease Neuroimaging Initiative: reports from the 2011 Friday Harbor conference.Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritableMCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes.Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factorsBiomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tauAntisaccade task reflects cortical involvement in mild cognitive impairmentBayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer's diseaseDifferent demographic, genetic, and longitudinal traits in language versus memory Alzheimer's subgroups.Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome.Systematic review of neuroimaging correlates of executive functioning: converging evidence from different clinical populations.Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?Longitudinal Executive Function and Episodic Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.Comparing the Neuropsychiatric Profile of Patients with Alzheimer Disease Who Present Spared versus Impaired Executive Functioning.Approach to atypical Alzheimer's disease and case studies of the major subtypes.A clinicopathological approach to the diagnosis of dementia.Elizabeth Warrington Prize Lecture. Seeing why they cannot see: understanding the syndrome and causes of posterior cortical atrophy.Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria.Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
P2860
Q27006831-45289763-EBBB-4271-A905-434D7AFCBAB1Q28542010-07FC8889-8E71-446C-8899-EE6C0BD49A75Q28686824-87A6CFB0-D946-490A-BCF8-E6C42FD1704FQ30530793-0E28A872-1E84-4E86-BF28-CD133D37FF0EQ30666527-4B091D32-AE66-436A-BA2E-57A54AE03DA7Q30724134-64DBA137-57C9-4DB7-9CEA-124DA1B9AA5CQ30971403-5D5F06C8-B253-4A43-AB47-C2E747FEC839Q33565271-B2E22312-2E36-4B79-B23D-8895D8B2443CQ34065449-3B14D3CF-5BCE-46B5-B0EA-A4E3249825A9Q34591279-57928A22-D10F-4283-9743-DEA54F8947F5Q34714604-8CFA8721-7B26-41D1-8D34-DD1FF5901589Q34766236-D0E07DE4-B6E8-47D4-889D-944D143296E1Q35100330-B3F08863-6ED8-4250-87F1-DA9D062BC6C5Q35672676-7217B4FA-499F-4F8F-8D46-FFC2AF00E5BCQ35776171-6EBBE6B1-01E4-45DA-98E1-5C097B820924Q35855414-215E9774-FE60-4F74-BFF1-36D4083CB568Q36202834-7B572185-EEF2-47E1-B72D-8950D9038E58Q36217479-1DE0493E-15BF-46FA-BE93-BFE8AD65BE6EQ36304533-BDF9638C-A1CD-4BFA-A847-C587D7A68F30Q36494731-809B56D0-A945-46DB-AECE-C55CD93FEC41Q36494813-10F91546-D870-427E-AD50-0DE46FE79D9DQ36831778-679963A5-43F9-42DC-B29D-39BCFE7BC9BEQ37085329-39EF1F7D-9355-4134-96B0-E543B2EF9595Q37107704-92F89E98-4F80-4C69-AD37-EDC6D4DEC91DQ37226336-156EF829-A9BE-41A2-8C60-C91FD8403CAAQ37227071-70AC00FE-4853-4661-85B6-D97BA5AD72CEQ37369443-0DC0CD03-5129-44EC-BD8D-19A3FC84C9B3Q37408596-6E205BEF-9DF8-4336-801C-D709C24665D7Q37424456-77E368BE-4F74-41E0-B281-0E32B5C741BDQ37653352-BB1AC96F-5660-4298-B45F-B1AF7A4C1E61Q38206959-381839A3-621E-4C1B-BCFD-F8DA3AC127FAQ38271876-59DE1704-9B5C-416D-9D99-EE97E8375D26Q38810312-65032FFF-439C-4CC1-BB32-1B652035F90BQ38897445-84E28D79-9073-436F-8FAC-CF6579B23357Q39135327-CED89FE8-C885-486D-A20F-E37406FEF7E5Q39434968-CEF94078-622F-4BBA-9C27-B39FBDE19516Q44971600-4AD2138A-67C7-45C5-A54F-18807E5BFCEBQ46191036-EE2AD851-B250-4AD2-8B19-D5BDCFABA82DQ46398713-AE878965-9040-4007-9A0E-0570307DB102Q47588927-A7F6BA67-CF21-47F6-8D69-2BFF417792A9
P2860
Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@ast
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@en
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@nl
type
label
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@ast
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@en
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@nl
prefLabel
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@ast
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@en
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@nl
P2860
P356
P1476
Dysexecutive versus amnesic ph ...... ical thinning characteristics.
@en
P2093
Bradford C Dickerson
David A Wolk
P2860
P356
10.1136/JNNP.2009.199505
P407
P577
2010-06-20T00:00:00Z